GO
Loading...

Science

More

  • What is ALS?     Friday, 15 Aug 2014 | 7:32 AM ET

    CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.

  • 10 economies hit hard by climate change Thursday, 14 Aug 2014 | 4:41 AM ET

    CNBC looks at which countries may be worst hit, both environmentally and economically, by climate change.

  • VOTE: Are we ready for genetically modified babies? Monday, 11 Aug 2014 | 2:44 PM ET

    Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.

  • Therapies in early development for Ebola     Monday, 11 Aug 2014 | 1:07 PM ET

    CNBC's Meg Tirrell reports the World Health Organization has convened a panel of medical ethicists to discuss the potential treatment for Ebola patients with experimental therapies.

  • Study: Keystone carbon pollution more than figured Sunday, 10 Aug 2014 | 1:08 PM ET

    WASHINGTON— The much-debated Keystone XL pipeline could produce four times more global warming pollution than the State Department calculated earlier this year, a new study concludes.

  • Changing compassionate use     Friday, 8 Aug 2014 | 3:12 PM ET

    With the World Health Organization declaring Ebola an international public health emergency, CNBC's Meg Tirrell discusses the use of experimental drugs as a last resort to treat patients stricken with Ebola, cancer and other disease.

  • Tracking Ebola     Friday, 8 Aug 2014 | 11:38 AM ET

    The World Health Organization has declared the Ebola virus an international public health emergency. CNBC's Meg Tirrell reports the details.

  • Tekmira's Ebola program gets good news     Thursday, 7 Aug 2014 | 4:54 PM ET

    The FDA has ruled to allow the potential use of drug maker Tekmira's Ebola drug on patients, reports CNBC's Meg Tirrell.

  • Is US prepared for a pandemic?     Thursday, 7 Aug 2014 | 1:21 PM ET

    Irwin Redlener author of "Americans at Risk," weighs in on the Ebola outbreak and discusses if the U.S. is adequately prepared to handle an epidemic.

  • President Obama discusses the Ebola outbreak, and the unproven and untested drug in the U.S. that appears to be helping infected American patients.

  • Trouble with experimental treatments     Wednesday, 6 Aug 2014 | 2:25 PM ET

    Tom Geisbert, University of Texas Medical Branch, shares concerns for experimental treatments for the Ebola virus.

  • Ebola & the business of vaccines     Tuesday, 5 Aug 2014 | 3:18 PM ET

    Darria Long Gillespie, Emory University Hospital emergency physician, discusses at what point companies will begin to invest in vaccines to treat rare diseases like Ebola.

  • Global response to Ebola     Tuesday, 5 Aug 2014 | 3:16 PM ET

    CNBC's Eamon Javers reports two American aid workers infected with Ebola are being treated at Emory Hospital in Atlanta today and the U.S. Centers for Disease Control and Prevention is sending 50 additional experts to Africa.

  • Enormous hype about Ebola: Doctor     Tuesday, 5 Aug 2014 | 2:17 PM ET
    Members of Doctors Without Borders (MSF) put on protective gear at the isolation ward of the Donka Hospital, on July 23, 2014 in Conakry.

    Breaking down the realistic threat of Ebola, and whether hospitals are prepared, with Dr. Peter Hotez, M.D. of Baylor College of Medicine.

  • Risk & compassionate use drug requests     Tuesday, 5 Aug 2014 | 1:30 PM ET

    Compassionate use is a way for companies to provide experimental drugs outside of clinical trials for patients with no other options. CNBC's Meg Tirrell reports on the risks for patients and drug makers.

  • Ebola patient Writebol arrives in Atlanta     Tuesday, 5 Aug 2014 | 1:19 PM ET

    The second American with Ebola has arrived in Atlanta, reports CNBC's Sue Herera.

  • Germ-zapping robot on 'Power Lunch'     Tuesday, 5 Aug 2014 | 1:19 PM ET

    Xenex Disinfection Services hopes to fight the war against Ebola. Its CEO Morris Miller shares a demonstration of the company's disinfection robot Sara, which he claims can destroy a deadly virus in 5-10 minutes.

  • Battle for experimental drugs     Tuesday, 5 Aug 2014 | 11:26 AM ET

    CNBC's Meg Tirrell explains how patients with serious diseases, who have exhausted hope from medicines on the market, turn to compassionate use campaigns.

  • NBC's Jay Gray reports Ebola patient Nancy Writebol will arrive at Emory Hospital in Atlanta today.

  • Battling a rare cancer: Nathalie's story     Tuesday, 5 Aug 2014 | 7:30 AM ET

    Nathalie Traller, a 15-year-old cancer patient, talks about the challenges of getting access to experimental treatments for a rare form of the disease.